Aganepag
Aganepag is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM, and shows no activity at EP4 receptor. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention.
Product Specifications
CAS Number
910562-18-4
Product Name Alternative
AGN 210937
UNSPSC
12352005
Target
Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Aganepag.html
Purity
99.71
Solubility
DMSO : ≥ 45 mg/mL
Smiles
O=C(C1=CC=C(CCC[C@@H](CC2)N(C3=CC=C([C@@H](O)CCCCC)C=C3)C2=O)S1)O
Molecular Formula
C24H31NO4S
Molecular Weight
429.57
References & Citations
[1]Robert M. Burk, et al. Compounds and methods for skin repair. WO2014078434A1
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EP
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![2-Bromo-N-[ (2-fluorophenyl) methyl]-3-methylbutanamide](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
RQB72655-01 100 mg
2-Bromo-N-[ (2-fluorophenyl) methyl]-3-methylbutanamide
Sign In for Pricing
View Details RQB72655-02 1 g
2-Bromo-N-[ (2-fluorophenyl) methyl]-3-methylbutanamide
Sign In for Pricing
View Details 
